Clinical Trials in Ohio

Showing 6961-6980 of 20,938 trials

Wound Assessment Using Spectral Imaging US

NCT05415683

During the observational, non-interventional study, at Baseline Study Visit (BSV) subjects will be screened and consented. Eligible subjects will undergo imaging with the DeepView device. Pre- and post-debridement images will be obtained (if debridement performed per SOC), as well as reviewing medical history and physical assessments. Additional Study Visits (SVs) will be performed when patient returns to the clinic for Routine Clinic Visit for up to 12 weeks or wound closure. During these visits DeepView imaging will occur pre- and post-debridement, and the status of the subject's treatment will be recorded.

DiabetesDiabetic FootDiabetic Foot Ulcer

SpectralMD400 participantsStarted Jun 2022

Encino, California, United States • Los Angeles, California, United States • Lake Success, New York, United States +8 more locations

COMPLETEDPhase 327 miles

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

NCT02783729

This study will be conducted to demonstrate, using polysomnography, that lemborexant 10 milligrams (mg) and 5 mg is superior to placebo on objective sleep onset as assessed by latency to persistent to sleep (LPS) after the last 2 nights of 1 month of treatment in participants 55 years and older with insomnia disorder.

Insomnia

Eisai Inc.1,006 participantsStarted May 2016

Jasper, Alabama, United States • Glendale, Arizona, United States • Little Rock, Arkansas, United States +99 more locations

Wound Assessment Using Spectral Imaging US

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Find Trials by Condition in Ohio

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

EnSite Precision Observational Study

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer